Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-91.88	-7.36	90.66
Graham Fair Price	41.42	1.11	0.79
PEG	-62.43	-0.07	0.19
Price/Book	-4.04	2.27	2.36
Price/Cash Flow	-51.55	69.02	142.46
Prices/Earnings	52.02	-7.23	-15.06
Price/Sales	-43.54	3.95	7.00
Price/FCF	-51.55	69.02	142.46
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	70.78	-0.72	0.42
Operating Margin	-484.57	-0.69	-0.12
ROA	-97.93	-0.03	-0.02
ROE	-0.04	-0.08	-99.99
ROIC	-0.03	-0.25	-795.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.53	0.98	-46.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.81	-8.93	1000.61
EPS QOQ	0.78	-1.00	27.71
FCF QOQ	1.13	0.98	-13.33
Revenue QOQ	-0.29	0.70	142.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-32.49	-6.40	80.30
Days Sales Outstanding (DSO)	149.78	104.54	-30.20
Inventory Turnover	-2.77	-14.06	-407.68
Debt/Capitalization	0.33	0.36	8.58
Quick Ratio	1.26	1.73	37.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.84	0.84	< 0.005
Cash	0.60	0.60	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.01	0.03	98.08
Revenue	0.28	0.48	69.95
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.55	2.00	29.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.38	1.63	-74.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating